Richard Blomfeldt1, Piotr Kasina2, Carin Ottosson2, Anders Enocson2, Lasse J Lapidus2. 1. Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden. richard.blomfeldt@ki.se. 2. Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden.
Abstract
PURPOSE: Prosthetic joint infections (PJIs) occur on a regular basis and with an increasing incidence. Under reporting of complications to national registries and unreliable ICD-10 coding increases the risk of under estimating the true rate of PJIs after hip arthroplasty. Also, the microbiology and final outcome is less well described, especially for hip-fracture patients operated upon with primary and secondary fracture prostheses. Our aim was to analyse re-operation rate, outcome and microbiology of PJIs following hip arthroplasty in patients operated upon due to hip fractures and degenerative hip disorders. METHODS: This was a single-centre cohort study of 3807 consecutive hip arthroplasties performed between 1996 and 2005. The primary study outcome was to compare the incidence of PJIs. The secondary outcome was to analyse the microbiology and outcome of PJIs. RESULTS: We identified 62 PJIs: seven surgical-site PJIs were found in patients operated upon for a degenerative hip disorder, 22 [hazard ratio (HR) 4.3] were found in patients operated upon for a primary fracture and prosthesis and 25 (HR 6.1) in patients operated upon with a secondary fracture and prosthesis. Outcome treatment was unfavourable for hip fracture patients with a high rate of Girdlestone operation performed (22 of 27). Staphylococcal infections dominated in the fracture group, whereas polybacterial infections were more common in patients with degenerative hip disorder. CONCLUSIONS: Patients with a displaced femoral neck fracture treated primary or secondary with arthroplasties have a greater risk of PJIs and display worse outcomes compared with patients with a total hip replacement due to degenerative hip disorders.
PURPOSE: Prosthetic joint infections (PJIs) occur on a regular basis and with an increasing incidence. Under reporting of complications to national registries and unreliable ICD-10 coding increases the risk of under estimating the true rate of PJIs after hip arthroplasty. Also, the microbiology and final outcome is less well described, especially for hip-fracturepatients operated upon with primary and secondary fracture prostheses. Our aim was to analyse re-operation rate, outcome and microbiology of PJIs following hip arthroplasty in patients operated upon due to hip fractures and degenerative hip disorders. METHODS: This was a single-centre cohort study of 3807 consecutive hip arthroplasties performed between 1996 and 2005. The primary study outcome was to compare the incidence of PJIs. The secondary outcome was to analyse the microbiology and outcome of PJIs. RESULTS: We identified 62 PJIs: seven surgical-site PJIs were found in patients operated upon for a degenerative hip disorder, 22 [hazard ratio (HR) 4.3] were found in patients operated upon for a primary fracture and prosthesis and 25 (HR 6.1) in patients operated upon with a secondary fracture and prosthesis. Outcome treatment was unfavourable for hip fracturepatients with a high rate of Girdlestone operation performed (22 of 27). Staphylococcal infections dominated in the fracture group, whereas polybacterial infections were more common in patients with degenerative hip disorder. CONCLUSIONS:Patients with a displaced femoral neck fracture treated primary or secondary with arthroplasties have a greater risk of PJIs and display worse outcomes compared with patients with a total hip replacement due to degenerative hip disorders.
Authors: Donna M Urquhart; Fahad S Hanna; Sharon L Brennan; Anita E Wluka; Karin Leder; Peter A Cameron; Stephen E Graves; Flavia M Cicuttini Journal: J Arthroplasty Date: 2009-10-30 Impact factor: 4.757
Authors: Ho-Rim Choi; Fabian von Knoch; Abdurrahman O Kandil; David Zurakowski; Slade Moore; Henrik Malchau Journal: Int Orthop Date: 2011-07-27 Impact factor: 3.075
Authors: Robert A Malinzak; Merrill A Ritter; Michael E Berend; John B Meding; Emily M Olberding; Kenneth E Davis Journal: J Arthroplasty Date: 2009-07-15 Impact factor: 4.757
Authors: Bart A Swierstra; Anton M J S Vervest; Geert H I M Walenkamp; B Wim Schreurs; Pieter T J Spierings; Ide C Heyligers; Job L C van Susante; Harmen B Ettema; Mariette J Jansen; Pim J Hennis; Janneke de Vries; Sabrina B Muller-Ploeger; Margreet A Pols Journal: Acta Orthop Date: 2011-10 Impact factor: 3.717
Authors: Mike B Anderson; Karen Curtin; Jathine Wong; Christopher E Pelt; Christopher L Peters; Jeremy M Gililland Journal: J Bone Joint Surg Am Date: 2017-06-07 Impact factor: 5.284
Authors: Dariusz Marczak; Marek Synder; Marcin Sibiński; Michał Polguj; Julian Dudka; Jacek Kowalczewski Journal: Int Orthop Date: 2017-05-18 Impact factor: 3.075